Eupraxia Pharmaceuticals Inc.

TSX:EPRX.TO

4.25 (CAD) • At close November 14, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) CAD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q3
Revenue 002.97900000000000000000
Cost of Revenue 0.0580.051.4890.050.0490.0490.0550.050.0490.0390.0410.030.020.02000000
Gross Profit -0.058-0.051.489-0.05-0.049-0.049-0.055-0.05-0.049-0.039-0.041-0.03-0.02-0.02000000
Gross Profit Ratio 000.500000000000000000
Reseach & Development Expenses 5.3895.5986.8746.0964.6852.9696.4943.8524.9111.9461.8273.5563.6260.67-0.2150.2860.3970.451-0.3950.712
General & Administrative Expenses 2.5832.518-0.1992.5932.8431.2622.2520.9661.1831.4061.5731.4771.3324.5060.2350.30.2580.4920.6730.817
Selling & Marketing Expenses 00.860001.82800000000000000
SG&A 2.5833.378-0.1992.5932.8431.832.2520.9661.1831.4061.5731.4771.3324.5060.2350.30.2580.4920.6730.817
Other Expenses 000000000000-0.325-1.936000000
Operating Expenses 8.9128.9766.5278.8847.6494.7998.8024.8686.1433.3923.4415.0634.9785.1950.0410.6060.6760.9950.3311.578
Operating Income -6.555-9.027-6.349-8.624-7.445-4.847-8.575-4.675-6.028-3.356-3.41-5.043-5.288-7.131-0.062-0.606-0.676-0.995-0.331-1.567
Operating Income Ratio 00-2.13100000000000000000
Total Other Income Expenses Net -1.7490.73-4.4722.076-0.556-0.195-0.509-0.119-0.251-0.403-0.368-0.092-0.307-3.666-0.078-0.122-0.049-0.523-0.281-0.192
Income Before Tax -8.304-8.296-4.315-6.548-8.001-5.042-9.083-4.795-6.28-3.76-3.777-5.135-5.595-8.862-0.14-1.062-0.99-2.153-0.713-1.759
Income Before Tax Ratio 00-1.44800000000000000000
Income Tax Expense -0.0050.007-0.2910.1990.39-0.0820.2030.2810.180.2660.2770.163-0.298-1.4860.4080.3920.4950.5460.5460.353
Net Income -6.007-8.15-4.096-6.314-7.827-4.96-8.823-4.656-6.09-3.691-3.718-4.974-5.437-8.86-0.138-1.06-0.983-2.146-0.735-1.745
Net Income Ratio 00-1.37500000000000000000
EPS -0.23-0.28-0.15-0.25-0.36-0.23-0.41-0.22-0.31-0.26-0.3-0.35-0.41-1.13-0.011-0.082-0.076-0.170-0.14
EPS Diluted -0.23-0.28-0.15-0.25-0.36-0.23-0.41-0.22-0.31-0.26-0.3-0.35-0.41-1.13-0.011-0.082-0.076-0.170-0.14
EBITDA -8.912-8.976-10.519-6.065-7.396-4.799-8.519-4.625-5.98-3.317-2.644-5.014-5.268-7.1110.313-0.585-0.34-1.091-0.135-1.517
EBITDA Ratio 00-2.12900000000000000000